ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 185 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,000 | -89.2% | 500 | -88.5% | 0.00% | – |
| Q2 2015 | $37,000 | +1133.3% | 4,363 | +990.8% | 0.00% | – |
| Q1 2015 | $3,000 | -91.4% | 400 | -92.2% | 0.00% | – |
| Q4 2014 | $35,000 | 0.0% | 5,100 | -19.0% | 0.00% | – |
| Q3 2014 | $35,000 | -72.2% | 6,300 | -68.0% | 0.00% | -100.0% |
| Q2 2014 | $126,000 | +142.3% | 19,664 | +204.2% | 0.00% | +100.0% |
| Q1 2014 | $52,000 | +147.6% | 6,464 | +113.3% | 0.00% | – |
| Q4 2013 | $21,000 | -61.1% | 3,031 | +4.9% | 0.00% | -100.0% |
| Q3 2013 | $54,000 | +5300.0% | 2,890 | +3858.9% | 0.00% | – |
| Q2 2013 | $1,000 | – | 73 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $80,313,000 | 15.61% |
| Opaleye Management Inc. | 1,310,000 | $8,188,000 | 3.42% |
| Camber Capital Management LP | 5,405,235 | $33,783,000 | 2.18% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 471,516 | $2,947,000 | 1.22% |
| HighVista Strategies LLC | 807,100 | $5,044,000 | 0.94% |
| JS Capital Management LLC | 630,000 | $3,938,000 | 0.94% |
| 1492 Capital Management LLC | 202,500 | $1,266,000 | 0.92% |
| Palo Alto Investors LP | 2,257,217 | $14,108,000 | 0.78% |
| Geduld E E | 185,100 | $1,157,000 | 0.72% |
| Elk Creek Partners, LLC | 1,592,527 | $9,953,000 | 0.71% |